Two issues may justify this high percentage of mutated samples: the high sensitivity of PNA (compared to IHC and most to Sanger Sequencing) and the high prevalence, in our population, of melanomas in sites not chronically sun exposed (CSE) as trunk and limbs (Table 1), which are known to be associated with BRAF mutation [41]. The gene discussed is BRAF; the disease is melanoma.